The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...

The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

At the first meeting of a controversial new group of vaccine advisers to the US Centers for Disease Control and Prevention, ...

The chair of the CDC’s newly remade vaccine advisory committee said Wednesday that the committee will be reviewing existing ...

The CDC's vaccine advisory committee is set to meet for the first time since HHS Secretary Robert F. Kennedy Jr. dismissed ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

A startling new vision of vaccination in America is becoming clearer — one likely to involve fresh scrutiny of established science and practices, and limits on vaccines that have been studied for ...